17 min listen
New Means to Reactivate p53 in Leukemia With Drs. Omar Abdel-Wahab, Ulrich Steidl, and Amit Verma
FromThe Hematologist
New Means to Reactivate p53 in Leukemia With Drs. Omar Abdel-Wahab, Ulrich Steidl, and Amit Verma
FromThe Hematologist
ratings:
Length:
24 minutes
Released:
Jul 2, 2018
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Omar Abdel-Wahab has a conversation with Drs. Ulrich Steidl and Amit Verma. They discuss Dr. Abdel-Wahab's Diffusion article from the July/August 2018 issue of The Hematologist. The article titled, "New Means to Reactivate p53 in Leukemia: A Staple Peptide Inhibitor of MDMX and MDM2," discusses therapeutic activation of wild-type TP53 in leukemia and other forms of cancer. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8673.aspx.
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Jul 2, 2018
Format:
Podcast episode
Titles in the series (100)
Navigating Future Challenges in Lymphoma: The strategic roadmap developed at the original ASH Meeting on Lymphoma Biology held in August 2014 was recently published in Blood. To continue this important conversation, Dr. Ann LaCasce (Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA by The Hematologist